Millennium Management’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Millennium Management’s Portfolio SRRA Stock Details SRRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-132,187	Closed	-$4.24M	–	7816
2022 Q1	$4.24M	Buy	+132,187	New	+$3.79M	﹤0.01%	3116
2021 Q4	–	Sell	-98,131	Closed	-$2.15M	–	7697
2021 Q3	$2.15M	Sell	98,131 -8,003	-8%	-$160K	﹤0.01%	3826
2021 Q2	$2.07M	Sell	106,134 -14,812	-12%	-$269K	﹤0.01%	3914
2021 Q1	$2.08M	Buy	120,946 +14,092	+13%	+$223K	﹤0.01%	3493
2020 Q4	$1.71M	Sell	106,854 -17,912	-14%	-$249K	﹤0.01%	3358
2020 Q3	$1.33K	Buy	+124,766	New	+$1.49M	﹤0.01%	2925
2019 Q2	–	Sell	-977	Closed	-$67K	–	4640
2019 Q1	$67K	Sell	977 -405	-29%	-$26K	﹤0.01%	3888
2018 Q4	$73K	Sell	1,382 -33,968	-96%	-$2.17M	﹤0.01%	3585
2018 Q3	$2.4M	Sell	35,350 -20,722	-37%	-$1.88M	﹤0.01%	2319
2018 Q2	$6.64M	Sell	56,072 -939	-2%	-$94.2K	0.01%	1609
2018 Q1	$4.72M	Buy	57,011 +26,465	+87%	+$3M	0.01%	1838
2017 Q4	$4.56M	Buy	30,546 +6,746	+28%	+$648K	0.01%	1782
2017 Q3	$1.48M	Buy	23,800 +22,785	+2,245%	+$1.34M	﹤0.01%	2321
2017 Q2	$47K	Sell	1,015 -1,798	-64%	-$91.8K	﹤0.01%	3366
2017 Q1	$172K	Buy	2,813 +1,588	+130%	+$92.3K	﹤0.01%	3245
2016 Q4	$73K	Buy	+1,225	New	+$76.4K	﹤0.01%	3223
2016 Q3	–	Sell	-895	Closed	-$71K	–	3728
2016 Q2	$71K	Buy	895 +152	+20%	+$29K	﹤0.01%	3054
2016 Q1	$200K	Buy	+743	New	+$237K	﹤0.01%	2958
2015 Q4	–	Sell	-2,774	Closed	-$2.28M	–	3882
2015 Q3	$2.28M	Buy	+2,774	New	+$3.13M	﹤0.01%	1815

Other funds holding SRRA

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Millennium Management's SRRA Position: Q2 2022 in Review

Millennium Management sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q2 2022, closing a stake of 132,187 shares — an estimated $4.24M sold.

Millennium Management first reported a position in SRRA in Q3 2015 and held it in 19 quarters. The position peaked at $6.64M in Q2 2018. 109 funds tracked by Wall St. Rank hold SRRA as of Q2 2022.

Millennium Management reported no remaining Sierra Oncology, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Millennium Management sold 132,187 Sierra Oncology, Inc. Common Stock shares in Q2 2022, an estimated $4.24M.
Millennium Management first reported a position in Sierra Oncology, Inc. Common Stock in Q3 2015 and held it in 19 quarters.
Millennium Management's Sierra Oncology, Inc. Common Stock position peaked at $6.64M in Q2 2018.
109 funds tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q2 2022.

Based on Millennium Management's 13F filing for Q2 2022, filed 15 Aug 2022.